Methylmalonic acid: the forgotten test that reveals your true B12 status

Key Takeaways

• MMA is the most sensitive functional marker of B12 status at the cellular level¹ — it rises when your mitochondria cannot process amino acids, fatty acids, and cholesterol through the MUT enzyme pathway.
• The enzyme MUT (methylmalonyl-CoA mutase) requires adenosylcobalamin as its cofactor² — not methylcobalamin and not cyanocobalamin. Most B12 supplements contain the wrong form for this enzyme.
• Lab reference ranges report MMA as “in range” up to 335 nmol/L³, but population data show mortality risk increases meaningfully well below that ceiling.
• MMA above 250 nmol/L combined with normal serum B12 is associated with 2.4 times higher all-cause mortality risk⁴ compared to those with low MMA and adequate B12 — serum B12 alone shows no significant mortality signal.
• High intake of odd-chain fatty acids and elevated oxidative stress both increase the substrate load flowing into the MUT pathway⁵, raising MMA even when adenosylcobalamin appears adequate.
• Variants in the MMUT gene reduce enzyme activity²; even partial reductions compound the problem when adenosyl-B12 and CoA availability are suboptimal.
• Pantothenic acid (vitamin B5) is required for CoA synthesis⁶ — the same CoA molecules that propionyl-CoA, methylmalonyl-CoA, and succinyl-CoA need to transit the entire MUT pathway.
• The functional optimal target is MMA below 150–200 nmol/L, not just under 335. “In range” and “optimal” are not the same question.

My lab said I was fine. The research said otherwise.

I am 52 years old. My biological age tests at 42.2.

I have spent decades studying nutrigenomics, methylation, and how to run a cleaner metabolism. I eat organic. I take targeted supplements. I know my genetics. By most measures, the system is working.

Then my MMA came back at 242 nmol/L. The lab reported it green. “In Range,” it said.

I did not agree.

Not because 242 is alarming on its own. It is not. But I had read the research. I knew what the studies showed about MMA at the upper end of the reference range, and I knew that “in range” and “optimal” are entirely different things.

This is the point. Even when you are doing most things right — even when your biological age runs a decade younger than your chronological age — there are specific metabolic blind spots that go undetected unless you know which tests to run. MMA is one of them. Most people have never heard of it. Most doctors never order it. Most labs will tell you anything under 335 is perfectly fine.

None of that is correct. Here is what you need to know:

What is methylmalonic acid, and why does it matter?

MMA is a metabolic byproduct your body produces constantly as it breaks down four amino acids (valine, isoleucine, methionine, and threonine), odd-chain fatty acids, and cholesterol.⁷ Under normal circumstances, MMA stays low because your cells convert it rapidly into succinyl-CoA, a molecule that feeds directly into the Krebs cycle to drive energy production.⁸

When MMA rises, that conversion is stalling. The pathway is backing up.

Most clinicians use MMA as a follow-up test when serum B12 looks borderline. That framing undersells it significantly. MMA is a direct window into whether your cells are using B12 effectively at the mitochondrial level.⁹ You can have a serum B12 of 500, 600, even 800 pg/mL and still have elevated MMA. That situation — normal or high serum B12 with elevated MMA — is what researchers now call functional B12 deficiency, and it is far more common than most clinicians recognize.¹⁰

Functional B12 deficiency means your blood has plenty of B12 in transit, but your cells are not converting it into the active form your mitochondria actually need. Serum B12 misses this entirely. MMA catches it.

Meet MUT: the mitochondrial enzyme no one talks about

The enzyme at the center of this story is methylmalonyl-CoA mutase, encoded by the MMUT gene and referred to simply as MUT.

MUT sits inside your mitochondria and catalyzes one critical reaction: the conversion of L-methylmalonyl-CoA into succinyl-CoA.⁹ That step funnels metabolites from branched-chain amino acids and fatty acid oxidation into the Krebs cycle. Without it, methylmalonyl-CoA backs up, loses its CoA group, and becomes free methylmalonic acid — the compound your blood test measures.

Here is what makes MUT unique and what makes it the forgotten B12 story: MUT requires adenosylcobalamin as its cofactor. Not methylcobalamin. Not cyanocobalamin.² Adenosylcobalamin.

Methylcobalamin supports methionine synthase and the methylation cycle. Adenosylcobalamin supports MUT and mitochondrial energy metabolism. These are separate B12-dependent pathways, and the cofactor requirements are not interchangeable.

When your adenosylcobalamin status is low — whether from inadequate intake, poor conversion, or impaired mitochondrial B12 transport — MUT activity drops, methylmalonyl-CoA accumulates, and MMA rises. This happens even when your serum B12 looks completely normal, because serum B12 measures total cobalamin in circulation, not the specific form your mitochondria are actually using.¹¹

This is why MMA is the forgotten B12 test. The test clinicians order (serum B12) does not reveal the problem MUT is having. MMA does.

Two Ways Your MUT Gene Gets Dirty

Like every gene in the Dirty Genes framework, MMUT can underperform in two ways: inherited variants and acquired dirtiness from lifestyle, diet, and environment.

Inherited MMUT Variants

Hundreds of mutations in the MMUT gene have been catalogued in ClinVar and OMIM. The most severe cause methylmalonic acidemia, a rare but life-threatening disorder that typically presents in infancy.¹² But severe pathogenic variants are not the only concern for a general wellness audience.

Heterozygous individuals — those who carry one normal copy and one reduced-function copy of MMUT — typically have mildly reduced enzyme activity without any clinical presentation. These partial-function variants are rare in the general population, and the variants that cause overt disease are rarer still. When both copies are severely affected, the result is a neonatal metabolic emergency — not something that goes undiagnosed into adulthood.¹²

Do you need genetic testing for MMUT?

Almost certainly not. Here is why.

Severe MMUT variants are among the most dramatic metabolic disorders in medicine. When both copies of the gene are non-functional (the mut0 phenotype), the result is life-threatening metabolic acidosis in the first days or weeks of life — projectile vomiting, lethargy, coma, and death without emergency intervention.¹² These infants are identified immediately, typically through newborn screening. Any adult reading this article who has not already been diagnosed with methylmalonic acidemia does not have a severe biallelic MMUT variant. You would already know.

Partial-function variants (the mut− phenotype) also present in infancy or early childhood with metabolic crises severe enough to require hospitalization. Again — not something that goes undiagnosed into adulthood.

For healthy adults with elevated MMA, the issue is almost never a severe genetic variant. It is cofactor insufficiency, dietary substrate load, impaired kidney function, gut dysbiosis, aging, or a combination of all five. These are lifestyle and nutrition variables — and they respond to the interventions in this article.

If you want to go deeper on your complete genetic picture — including the full MMUT coding sequence and hundreds of other metabolic genes — whole genome sequencing is the tool. SelfDecode and Sequencing.com both offer consumer WGS with health reporting. Unlike 23andMe or AncestryDNA, which use SNP chips that miss rare coding variants entirely, WGS reads every base of your genome. If a rare partial-function MMUT variant is present, WGS will find it.

Acquired Dirtiness: Lifestyle and Nutritional Factors

Your MMUT gene does not need an inherited variant to underperform. Any of the following can suppress MUT activity or increase MMA without a single SNP involved:

Substrate overload:

• High protein intake: the branched-chain amino acids valine and isoleucine, plus methionine and threonine, are primary propionate precursors. High-protein diets flood the MUT pathway with substrate.⁷
• High intake of odd-chain fats and cholesterol: Odd-chain fatty acids from ruminant animals (cows and goats), and cholesterol side chains both break down into three-carbon propionate precursors.
• Gut dysbiosis: bacteria in the colon produce propionate from fiber fermentation and undigested protein. Dysbiotic microbiomes increase the microbial propionate load reaching the liver.¹⁴

Substrate transport:

• Inadequate B5 status: Pantothenic acid (vitamin B5) forms the backbone of the coenzyme A molecule (CoA), needed to transport metabolites through the mitochondria.

Substrate utilization:

• Impaired mitochondrial function: MMA rises with age even in the absence of documented B12 deficiency, likely reflecting declining mitochondrial function, increased systemic inflammation, and reduced adenosylcobalamin transport efficiency.¹⁵
• Inadequate adenosyl-B12: the direct cofactor MUT requires. Low dietary intake, poor absorption (due to low stomach acid), poor conversion from cyano or hydroxo forms, or impaired mitochondrial B12 trafficking all reduce available adenosylcobalamin.¹¹
• Medications: metformin, proton pump inhibitors, and prolonged antacid use reduce B12 absorption and directly affect MMA over time.¹⁷

Overflow elimination:

• Impaired renal function: the kidneys excrete MMA; reduced glomerular filtration rate (GFR) slows clearance and raises plasma MMA independent of B12 status.¹⁶

How I Was Dirtying My MUT Enzyme

One underappreciated driver of MMA elevation is dietary fat — specifically odd-chain fatty acids.

Odd-chain fatty acids are concentrated in ruminant dairy (goat milk, goat cheese, goat yogurt, full-fat cow dairy) and ruminant meats. During beta-oxidation, they produce propionyl-CoA as their final breakdown product rather than the acetyl-CoA that even-chain fatty acids generate.⁷ That propionyl-CoA enters exactly the same pathway that MUT governs, converting to methylmalonyl-CoA and then on to succinyl-CoA.

My own situation made this connection undeniable. For months leading up to my April 2026 labs, I was consuming significant amounts of goat milk, goat cheese, and goat yogurt daily. I was hiking regularly but not doing sustained zone 2 cardio — the kind of training that builds the mitochondrial capacity to handle fatty acid substrate loads efficiently. I was also low on omega-3s and relatively high in omega-6 linoleic acid.

The result: I was flooding the MUT pathway with odd-chain fatty acid substrate, operating with an omega-3 deficit that limited anti-inflammatory fatty acid signaling, and not building the mitochondrial infrastructure to process the load cleanly. My MMA at 242 was the metabolic readout of that pattern.

Exercise type matters here. Sustained zone 2 cardio — maintaining heart rate at roughly 60 to 70% of maximum for extended periods — is the primary stimulus for increasing mitochondrial density and improving fatty acid oxidation efficiency.¹⁸ Hiking and short high-intensity efforts do not produce the same mitochondrial adaptation. Building a zone 2 base increases the capacity to clear propionyl-CoA cleanly, reducing MMA substrate pressure over time.

Oxidative stress can compound the problem at the mitochondrial level — though it was not a driver in my case. My hs-CRP came back at 0.3 mg/L and my liver and glutathione markers were all clean, confirming low systemic oxidative inflammation. For me, this was a substrate and cofactor story, not an oxidative stress story.

Research does show that when oxidative stress is present, elevated MMA inhibits electron transport complex II¹⁹ and suppresses alpha-ketoglutarate dehydrogenase — a rate-limiting Krebs cycle enzyme — by up to 73%.²⁰ That creates a feedback loop: elevated MMA generates more oxidative stress, which impairs mitochondrial function, which further slows MUT. If your inflammatory and oxidative markers are also elevated, that loop is active and needs to be addressed directly.

There is one more mechanism that deserves its own explanation: CoA trapping. This is underappreciated, underdiagnosed, and directly relevant to why pantothenic acid belongs in any MMA correction protocol.

CoA Trapping: Why Vitamin B5 Matters for MMA

The simple version:

CoA (coenzyme A) is the carrier molecule your cells attach to everything moving through the MUT pathway. Propionyl-CoA, methylmalonyl-CoA, succinyl-CoA — every step requires it. Think of CoA as the truck that moves metabolites from one enzyme to the next.

When MUT slows down or the pathway gets overloaded, propionyl-CoA and methylmalonyl-CoA pile up and stay attached to their CoA molecules. All those trucks are stuck in gridlock. The free CoA available for the rest of your metabolism — fatty acid synthesis, the Krebs cycle, amino acid processing — gets depleted.

Pantothenic acid (B5) is the raw material your body uses to build new CoA from scratch.⁶ Without adequate B5, you cannot replenish the free CoA pool fast enough to keep up with demand. The pathway stays gridlocked. More MMA accumulates. Even if you add adenosylcobalamin to speed up MUT, the CoA shortage limits throughput.

B5 and adenosyl-B12 work together. One restores the cofactor. The other restores the carrier. You need both.

How to test for B5/CoA insufficiency:

• Organic acids test (OAT): the most practical window into CoA pathway function. Elevated methylcitrate, 3-hydroxypropionate, and propionylcarnitine all reflect CoA trapping and propionate backup upstream of MUT. Genova Diagnostics and Great Plains Laboratory both offer OAT panels.
• Plasma pantothenate: B5 can be measured directly in blood. Less commonly ordered but available through functional labs. Low plasma pantothenate (<0.5 mg/L) signals insufficiency.
• Acylcarnitine panel: elevated C3 (propionylcarnitine) is a direct read on propionyl-CoA accumulation and CoA trapping. Available through most functional and metabolic labs.
• MMA itself: elevated MMA is partly a CoA story. If MMA stays elevated despite adequate adenosyl-B12, CoA trapping and B5 insufficiency are likely contributors.

My Labs: What a Loaded MUT Pathway Looks Like

Labs do not lie. When I reviewed my full April 2026 panel, the MMA story was written across multiple markers.

The pattern was clear: high odd-chain fatty acid substrate load driving a lipid and MMA picture that had nothing to do with insulin resistance, inflammation, or metabolic syndrome. My glucose, HbA1c, and insulin were all excellent. My hs-CRP was 0.3. This was not a sick person's lipid panel. It was a specific dietary substrate pattern showing up in the biochemistry.

The lipid pattern confirms the dietary driver. Elevated LDL particle number, small dense LDL, and high ApoB are classic signatures of a high saturated fat intake — specifically the type found in full-fat goat dairy. The omega-3 deficit compounds it: low omega-3s allow the omega-6:omega-3 ratio to drift, reducing the anti-inflammatory fatty acid signaling that counterbalances lipid-driven vascular risk.

None of this required a drug. It required identifying the dietary driver, removing it, and replacing it with the right fatty acid profile and the right cofactors.

What I Changed — and Why Each Piece Matters

Once the picture was clear, the protocol wrote itself. Each intervention targets a specific mechanism in the MUT pathway or the fatty acid substrate problem upstream of it.

Removed all goat dairy

Goat milk, goat cheese, and goat yogurt are rich in odd-chain fatty acids including C15:0 (pentadecanoic acid) and C17:0 (heptadecanoic acid). These are the direct dietary precursors to propionyl-CoA through beta-oxidation. Removing them is the most direct way to reduce the substrate flooding the MUT pathway. No supplement compensates for a diet that continuously floods the enzyme with more propionyl-CoA than it can clear.

Added wild salmon and increased fish oil

Wild salmon and fish oil provide EPA and DHA — long-chain omega-3 fatty acids. These are even-chain, meaning they produce acetyl-CoA rather than propionyl-CoA during beta-oxidation. They do not add to MMA substrate load. Instead, they correct the omega-3 deficit (my OmegaCheck was 5% against a target above 8%), reduce vascular inflammation, and support the lipid particle size shift from small dense LDL toward larger, less atherogenic particles.

Added acetyl-L-carnitine

Carnitine plays a direct role in the MUT pathway that is rarely discussed. When propionyl-CoA and methylmalonyl-CoA accumulate, they trap CoA in stalled intermediates. L-carnitine conjugates with propionyl-CoA to form propionylcarnitine, which can be transported out of the mitochondria and excreted in urine, releasing the trapped CoA back into the free pool.²¹ Acetyl-L-carnitine provides this carnitine shuttle function while also supporting mitochondrial acetyl-CoA metabolism. It is one of the more targeted and underappreciated interventions specifically relevant to propionate metabolism.

Adenosyl B12

This is the non-negotiable. MUT requires adenosylcobalamin. Not methylcobalamin, not cyanocobalamin. Supplementing with any other B12 form and expecting MMA to drop is like putting the wrong fuel in the tank.

The morning I started writing this article, I took two Optimal Adenosyl B12 lozenges sublingually. I felt a clearing of mental cobwebs within the hour that I had not experienced in months. Whether that is purely pharmacological or partly the expectation of someone who has just connected all the dots in their labs, I cannot prove. What I can say is that I wrote this entire article from that state.

Optimal Adenosyl B12 delivers adenosylcobalamin in a sublingual lozenge format that supports mitochondrial delivery.^† Suggested use: 1–2 lozenges daily, held under the tongue for full absorption. Sublingual delivery bypasses the digestive absorption steps that can limit oral B12 in people with gut or intrinsic factor issues.

Pantothenic acid (vitamin B5)

Once I understood the CoA trapping mechanism, B5 became a clear addition. The MUT pathway cannot clear efficiently without adequate free CoA, and CoA synthesis requires pantothenic acid as its rate-limiting precursor.⁶

Suggested use: 500–1,000 mg of pantothenic acid daily. Start at 500 mg and assess. B5 is water-soluble, well-tolerated, and safe at these doses. If your organic acids panel shows elevated methylcitrate, 3-hydroxypropionate, or propionylcarnitine, that is your signal that CoA trapping is active and B5 support is warranted.^†

Sustained zone 2 cardio

Zone 2 training — sustained effort at 60 to 70% of maximum heart rate for 45 minutes or longer — is the primary stimulus for mitochondrial biogenesis.¹⁸ More mitochondria means more capacity to process fatty acid substrate efficiently, more adenosylcobalamin active sites working in parallel, and better metabolic flexibility overall. Hiking without sustained zone 2 work was leaving a significant gap. Consistent zone 2 is now a non-negotiable part of how I manage this.

Signs Your MMA May Be Elevated

Because MMA reflects mitochondrial function and B12 utilization at the cellular level, elevated MMA tends to present as generalized mitochondrial insufficiency rather than a distinct syndrome. Symptoms are often vague and easy to attribute to aging, stress, or overtraining.

Cognitive and neurological signs appear first in many people: difficulty concentrating, brain fog, word-finding problems, declining memory, and peripheral tingling or numbness in the hands and feet.²² These reflect the brain's extreme dependence on mitochondrial energy production and B12-dependent myelin maintenance.

Physical signs include persistent fatigue that does not resolve with rest, reduced exercise tolerance, slow recovery after training, and unexplained muscle weakness.

Metabolic and cardiovascular signs include elevated homocysteine (which often co-occurs when combined functional B12 deficiency is present), impaired detoxification capacity, and reduced metabolic flexibility.

The challenge is that none of these symptoms point directly to MMA. Many people with elevated MMA are told their labs are normal, their B12 is fine, and there is nothing to explain how they feel. The MMA test is the piece that closes that gap.

This is what it looked like for me

My work is research, writing, and teaching. Those three things require sustained cognitive focus above almost anything else. When concentration starts slipping, I notice it immediately.

For several months I had been experiencing a gradual cognitive decline that I could not fully explain. Not dramatic. Not debilitating. But a kind of mental heaviness — like thinking through cobwebs — that was affecting my ability to stay sharp during long research and writing sessions.

I was already supporting with targeted brain nutrients, Optimal Focus, and glutathione. They helped. But something was still not right. The underlying heaviness persisted.

It was not until I ran a comprehensive panel through Function Health that the picture came together. My omega-3:omega-6 ratio was significantly imbalanced. Omega-6 linoleic acid was elevated at 32.5%. Omega-3 total was low at 5%. And my MMA was sitting at 242 — technically in range, but above the functional optimal zone.

My homocysteine came back at 8.2 umol/L. Quite good overall — this told me my methylation cycle was functioning reasonably well, and the MMA elevation was pathway-specific, not a broader methylation problem. I could fine-tune the homocysteine slightly, but the story was clearly in the MMA and fatty acid picture, not the methylcobalamin pathway.

That is what optimal feels like. And it is worth chasing with the right test and the right cofactor.

The Range Problem: "In Range" Is Not the Same as Optimal

My result was 242 nmol/L. Lab reference range: 55 to 335 nmol/L. Marked green. Technically acceptable.

Here is what the research actually shows.

In the Lifelines-MINUTHE prospective cohort study of 1,533 adults followed for 8.5 years, the median MMA in a healthy aging population was 170 nmol/L (interquartile range 138 to 216 nmol/L).¹⁶ That is the center of a healthy older population — not 335. My 242 sits 72 points above that median.

In the NHANES study of more than 23,000 adults, MMA was associated with all-cause mortality in a dose-dependent pattern, with no clear threshold below which risk disappeared.²³

A separate study in diabetic patients found that those with MMA at 250 nmol/L or above had 2.18 times the all-cause mortality risk compared to those below 120 nmol/L. CVD mortality risk tripled. Cancer-related mortality risk more than quadrupled.³

My 242 puts me just below that 250 threshold. Not in a danger zone. But not where I want to be. Not where you want to be either if you are thinking about long-term health, not just avoiding clinical disease.

The lab range tells you whether you have frank, clinically obvious functional B12 deficiency. The optimal range tells you whether your mitochondria are running well. These are different questions.

MMA and All-Cause Mortality: What the Research Shows

This is not a mild academic concern. Multiple large epidemiological studies now link circulating MMA to all-cause mortality, independent of serum B12.

A NHANES analysis of 23,437 adults found that elevated MMA was strongly and independently associated with higher all-cause and cardiovascular mortality over a median follow-up of 13.5 years.²³ The researchers positioned MMA as a surrogate biomarker of mitochondrial dysfunction, not just B12 status, because it reflects the cellular consequences of impaired energy metabolism and oxidative stress.

A 2026 NHANES study in adults with hyperlipidemia found that each unit increase in log-transformed MMA carried a 55% higher mortality risk after full multivariable adjustment.⁴ The highest-risk group was those with normal or high serum B12 but MMA above 250 nmol/L — the functional B12 deficiency pattern. Their adjusted hazard ratio for all-cause mortality was 2.40.

Serum B12 alone showed no significant mortality association in either study. MMA did.

That finding deserves emphasis. Your serum B12 may be completely normal. Your doctor may reassure you. But if your MMA is elevated, your mitochondria are telling a different story — and the research consistently suggests that story matters for long-term outcomes.

What to Do About Elevated MMA

If your MMA comes back elevated, or if it is sitting in the upper portion of the reference range like mine was, here is the framework.